|
1
|
Wagner MJ, Ricciotti RW, Mantilla J,
Loggers ET, Pollack SM and Cranmer LD: Response to PD1 inhibition
in conventional chondrosarcoma. J Immunother Cancer. 6:942018.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen JC, Huang C, Lee IN, Wu YP and Tang
CH: Amphiregulin enhances cell migration and resistance to
doxorubicin in chondrosarcoma cells through the MAPK pathway. Mol
Carcinog. 57:1816–1824. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sangma MM and Dasiah S: Chondrosarcoma of
a rib. Int J Surg Case Rep. 10:126–128. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murphey MD, Walker EA, Wilson AJ,
Kransdorf MJ, Temple HT and Gannon FH: From the archives of the
AFIP: Imaging of primary chondrosarcoma: Radiologic-pathologic
correlation. Radiographics. 23:1245–1278. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aigner T: Towards a new understanding and
classification of chondrogenic neoplasias of the
skeleton-biochemistry and cell biology of chondrosarcoma and its
variants. Virchows Arch. 441:219–230. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schoenfeld AJ, Hornicek FJ, Pedlow FX,
Kobayashi W, Raskin KA, Springfield D, DeLaney TF, Nielsen GP,
Mankin HJ and Schwab JH: Chondrosarcoma of the mobile spine: A
review of 21 cases treated at a single center. Spine (Phila Pa
1976). 37:119–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Staals EL, Bacchini P and Bertoni F:
Dedifferentiated central chondrosarcoma. Cancer. 106:2682–2691.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Grimer RJ, Gosheger G, Taminiau A, Biau D,
Matejovsky Z, Kollender Y, San-Julian M, Gherlinzoni F and Ferrari
C: Dedifferentiated chondrosarcoma: Prognostic factors and outcome
from a European group. Eur J Cancer. 43:2060–2065. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu L, de Vries E, Louwman M, Aben K,
Janssen-Heijnen M, Brink M, Coebergh JW and Soerjomataram I:
Prevalence of multiple malignancies in the Netherlands in 2007. Int
J Cancer. 128:1659–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng HY, Chu CH, Chang WH, Hsu TC, Lin
SC, Liu CC, Yang AM and Shih SC: Clinical analysis of multiple
primary malignancies in the digestive system: A hospital-based
study. World J Gastroenterol. 11:4215–4219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chrouser K, Leibovich B, Bergstralh E,
Zincke H and Blute M: Bladder cancer risk following primary and
adjuvant external beam radiation for prostate cancer. J Urol.
174:107–110. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brumback RA, Gerber JE, Hicks DG and
Strauchen JA: Adenocarcinoma of the stomach following irradiation
and chemotherapy for lymphoma in young patients. Cancer.
54:994–998. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Frederick LG, Carolyn CC, April G. Fritz
CTR, Jatin PS and David PW: AJCC Cancer Staging Atlas. Springer
Berlin. 2012.
|
|
15
|
Martin AM, Cagney DN, Catalano PJ, Warren
LE, Bellon JR, Punglia RS, Claus EB, Lee EQ, Wen PY, Haas-Kogan DA,
et al: Brain metastases in newly diagnosed breast cancer: A
population-based study. JAMA Oncol. 3:1069–1077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fromm J, Klein A, Baur-Melnyk A, Knösel T,
Lindner L, Birkenmaier C, Roeder F, Jansson V and Dürr HR: Survival
and prognostic factors in conventional central chondrosarcoma. BMC
Cancer. 18:8492018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rozeman LB, Hogendoorn PC and Bovee JV:
Diagnosis and prognosis of chondrosarcoma of bone. Expert Rev Mol
Diagn. 2:461–472. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giuffrida AY, Burgueno JE, Koniaris LG,
Gutierrez JC, Duncan R and Scully SP: Chondrosarcoma in the United
States (1973 to 2003): An analysis of 2890 cases from the SEER
database. J Bone Joint Surg Am. 91:1063–1072. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Savary M, Monnier P, Pasche R, Brossard E,
Pasche P and Lang F: Multiple primary malignancies. Adv
Otorhinolaryngol. 46:165–175. 1991.PubMed/NCBI
|
|
20
|
Armstrong GT, Liu W, Leisenring W, Yasui
Y, Hammond S, Bhatia S, Neglia JP, Stovall M, Srivastava D and
Robison LL: Occurrence of multiple subsequent neoplasms in
long-term survivors of childhood cancer: A report from the
childhood cancer survivor study. J Clin Oncol. 29:3056–3064. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rosso S, De Angelis R, Ciccolallo L,
Carrani E, Soerjomataram I, Grande E, Zigon G and Brenner H;
EUROCARE Working Group, : Multiple tumours in survival estimates.
Eur J Cancer. 45:1080–1094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Keller U, Grabenbauer G, Kuechler A,
Sprung CN, Müller E, Sauer R and Distel L: Cytogenetic instability
in young patients with multiple primary cancers. Cancer Genet
Cytogenet. 157:25–32. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Crocetti E, Buiatti E and Falini P;
Italian Multiple Primary Cancer Working Group, : Multiple primary
cancer incidence in Italy. Eur J Cancer. 37:2449–2456. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Heo J, Noh OK, Oh YT, Chun M and Kim L:
Second primary cancer after liver transplantation in hepatocellular
carcinoma: A nationwide population-based study. Hepatol Int.
11:523–528. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Q, Zhao S, Song Y, Gao P, Sun J, Chen
X, Sun Y and Wang Z: Do patients with second primary colorectal
cancer hold the similar prognosis and therapeutic benefits as those
with initial primary colorectal cancer? Biomed Res Int.
2018:Article ID 6172670. 2018. View Article : Google Scholar
|
